Bougras-Cartron, G.; Nadaradjane, A.; Joalland, M.-P.; Lalier-Bretaudeau, L.; Raimbourg, J.; Cartron, P.-F.
Adenosine Methylation Level of miR-125a-5p Promotes Anti-PD-1 Therapy Escape through the Regulation of IGSF11/VSIG3 Expression. Cancers 2023, 15, 3188.
https://doi.org/10.3390/cancers15123188
AMA Style
Bougras-Cartron G, Nadaradjane A, Joalland M-P, Lalier-Bretaudeau L, Raimbourg J, Cartron P-F.
Adenosine Methylation Level of miR-125a-5p Promotes Anti-PD-1 Therapy Escape through the Regulation of IGSF11/VSIG3 Expression. Cancers. 2023; 15(12):3188.
https://doi.org/10.3390/cancers15123188
Chicago/Turabian Style
Bougras-Cartron, Gwenola, Arulraj Nadaradjane, Marie-Pierre Joalland, Lisenn Lalier-Bretaudeau, Judith Raimbourg, and Pierre-François Cartron.
2023. "Adenosine Methylation Level of miR-125a-5p Promotes Anti-PD-1 Therapy Escape through the Regulation of IGSF11/VSIG3 Expression" Cancers 15, no. 12: 3188.
https://doi.org/10.3390/cancers15123188
APA Style
Bougras-Cartron, G., Nadaradjane, A., Joalland, M.-P., Lalier-Bretaudeau, L., Raimbourg, J., & Cartron, P.-F.
(2023). Adenosine Methylation Level of miR-125a-5p Promotes Anti-PD-1 Therapy Escape through the Regulation of IGSF11/VSIG3 Expression. Cancers, 15(12), 3188.
https://doi.org/10.3390/cancers15123188